Through
10/10
Paul Offit and Dorothy Roberts have been recognized for extraordinary accomplishments in their fields.
Penn’s infrastructure in both supporting clinical research and forging commercial partnerships smooths the way from idea to approval.
A new technique based on special cell-penetrating peptides promises advantages over current methods for editing the genomes of primary cells, such as patients’ T cells.
Since 2017, the FDA approved more than two dozen new therapies with roots at Penn Medicine—almost half of which are first-in-class for their indications.
A new Penn Medicine preclinical study finds that a new simultaneous “knockout” of two inflammatory regulators boosted T cell expansion to attach solid tumors.
School of Veterinary Medicine researchers have identified a cellular pathway that keeps Ebola virus from exiting human cells, with implications for developing new antivirals.
The Perelman School of Medicine’s E. John Wherry and Scott Hensley discuss the season’s confluence of COVID-19, influenza, and RSV and how our bodies are responding.
The results of a study led by Penn Medicine’s Carl June greenlights preclinical trials for the application of CAR T therapy in gel form to surgical wounds following partial tumor removal to eliminate residual tumor cells.
Recent research shows promise in a novel CAR T therapy after cancer relapse, and a novel treatment for multiple myeloma.
Penn Medicine researchers laud the early results for CAR T therapy in lupus patients, which point to broader horizons for the use of personalized cellular therapies.
Jean Bennett, Katalin Karikó, and Drew Weissman of the Perelman School of Medicine are noted for their advancements in gene therapy and mRNA technology.
FULL STORY →
According to Robert Vonderheide of the Perelman School of Medicine, the pandemic proved that mRNA vaccines could be used safely and developed quickly.
FULL STORY →
Robert Vonderheide of the Perelman School of Medicine says that a combined immunotherapy-vaccine approach could be a game changer for melanoma patients.
FULL STORY →
Carl June of the Perelman School of Medicine comments on the success of a new study using CAR-T cell therapy to combat tumors in children with a rare kind of cancer.
FULL STORY →
Scott Hensley of the Perelman School of Medicine and colleagues have developed a vaccine that could provide a baseline level of protection against all 20 known flu strains.
FULL STORY →
Scott Hensley of the Perelman School of Medicine says that children’s responses and vulnerability to future bouts of coronavirus may depend on the variants they encounter.
FULL STORY →